72
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Determination of Leflunomide in Pharmaceutical Tablets by Flow‐Injection Analysis

, &
Pages 1693-1701 | Received 20 Jan 2005, Accepted 28 Feb 2005, Published online: 20 Aug 2006
 

Abstract

A flow injection analysis (FIA) of leflunomide using UV‐detection is described, in this study. The most suitable carrier solvent was found to be an aqueous solution of ethanol (25%, v/v). Leflunomide was determined at the optimum conditions, such as flow rate of 0.8 mL · min−1 and detection wavelength of 260 nm. The method has been validated and linearity was examined in the range of 2.75×10−6−1.10×10−4 M. The limit of detection (LOD) and quantitation (LOQ) were calculated to be 2.60×10−7 M (S/N=3.3) and 7.87×10−7 M (S/N=10), respectively. The application of the proposed method has been performed in pharmaceutical tablets of leflunomide and excellent results were obtained. The results were compared with those obtained from UV‐spectrophotometry. Insignificant difference was found between the methods. As a result, the FIA method for the determination of leflunomide in pharmaceutical tablets can be proposed as a precise, accurate, sensitive, and cheap method for routine analysis laboratories.

Acknowledgment

The authors appreciate Anadolu University, Council of Research Project Fund for their support of chemicals and instruments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.